HGH (ProBLEN)


Welcome to the PulseAid listing for the HGH drug offered from ProBLEN. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: ProBLEN
NON-PROPRIETARY NAME: Human Growth Hormone (2 Parts), Hypophysis Suis (2 Parts), Hepar Suis (1 Part)
SUBSTANCE NAME: SOMATROPIN; SUS SCROFA PITUITARY GLAND; PORK LIVER
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: SPRAY
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 2016-11-23
END MARKETING DATE: 0000-00-00


HGH HUMAN OTC DRUG Details:

Item DescriptionHGH from ProBLEN
LABELER NAME: ProBLEN
DEA SCHEDULE:
ACTIVE STRENGTH: 30; 30; 6([hp_X]/mL; [hp_X]/mL; [hp_X]/mL)
START MARKETING DATE: 2016-11-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 43853-0013_e78878c8-6130-46fe-9812-f0b646416135
PRODUCT NDC: 43853-0013
APPLICATION NUMBER:

Other SOMATROPIN; SUS SCROFA PITUITARY GLAND; PORK LIVER Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Guangzhou Renuma Medical Systems Co., LtdHGH-Pro
Liddell Laboratories, Inc.Vital Age Defiance
Oxylife Nutritional Supplements IncGH
ProBLENHGH